FDA Inspection 1114817 — Versiti Wisconsin, Inc.
The FDA completed an inspection of Versiti Wisconsin, Inc. on December 13, 2019 in Milwaukee, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 13, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Milwaukee, WI (United States)